Awareness of OvaDx seems not that important till it is more or less ready to go to market. I've been in stocks where there's been 10 or more years of awareness (conferences, presentations, newspaper articles based on encouraging results etc. - by the way, I've mentioned that stock here previously; ONC or ONCY - great story in the making) but there's no indication that it will be receiving FDA approval anytime soon.
As for "cancer conferences", there would seem to be many of those each year although some are definitely bigger than others. The Austrailian ovarian test was debuted at a conference recently to some applause but its kind of a pre-awareness type of thing.
Tricky business this. But when OvaDx is ready to beunveiled, it should make significant ripples.
Market Data 
Markets 
AI
